Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

SELL
$2.13 - $7.13 $112 - $377
-53 Reduced 76.81%
16 $0
Q1 2023

Apr 28, 2023

BUY
$5.52 - $9.23 $380 - $636
69 New
69 $0
Q3 2022

Nov 08, 2022

BUY
$13.43 - $18.74 $778 - $1,086
58 Added 120.83%
106 $2,000
Q2 2022

Aug 10, 2022

BUY
$10.26 - $20.81 $492 - $998
48 New
48 $1,000

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $39.6M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.